Current challenges of severe acute respiratory syndrome coronavirus 2 seroprevalence studies among blood donors: A scoping review.
Sahar SaeedSamra UzicaninAntoine LewinRyanne Lieshout-KrikkeHelen M FaddyChristian ErikstrupCarla OsiowyClive R SeedWhitney R SteeleKaty L DavisonBrian S CusterSheila F O'Briennull nullPublished in: Vox sanguinis (2021)
By the end of 2020, seroprevalence rates were far from reaching herd immunity. In addition to differences in community transmission and diverse public health policies, study designs and methodology were likely contributing factors to seroprevalence heterogeneity.